Genome Sequence and Characterization of Acinetobacter Phage DMU1

Area of Science:

• Microbiology
• Virology
• Genomics

Background:

• Multidrug-resistant Acinetobacter baumannii infections pose a significant health threat due to treatment failures.
• There is a growing interest in bacteriophage therapy as an alternative treatment for resistant bacterial infections.

Purpose of the Study:

• To characterize Acinetobacter phage DMU1, isolated from activated sludge, for its potential as a therapeutic agent.
• To determine the morphological, genomic, and host range characteristics of Acinetobacter phage DMU1.

Main Methods:

• Electron microscopy for morphological analysis.
• Genome sequencing and comparative genomics for phylogenetic placement.
• Host range analysis to identify susceptible bacterial strains.

Main Results:

• Acinetobacter phage DMU1 exhibits morphology consistent with the Siphoviridae family.
• Genomic analysis reveals DMU1 is a siphophage most closely related to Acinetobacter phage SH-Ab 15497.
• Host range analysis indicates DMU1 infects only specific strains of Acinetobacter baumannii, including ATCC19606 and ATCC17978.

Conclusions:

• Acinetobacter phage DMU1 is a siphophage with potential for targeted therapy against specific Acinetobacter baumannii strains.
• Further research is warranted to explore the therapeutic efficacy and broader applications of DMU1.